Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
0.9431
+0.1007 (11.95%)
Nov 13, 2026, 4:00 PM EST - Market closed
Perspective Therapeutics Market Cap
Perspective Therapeutics has a market cap or net worth of $113.89 million as of November 13, 2026. It is the 24,073rd most valuable company in the world and the 3,952nd biggest in the United States. Its market cap has decreased by 27.74% in one year.
Market Cap
113.89M
Enterprise Value
-84.13M
1-Year Change
-27.74%
Global Rank
Country Rank
#3,952 United States
Category
ChartMarket Cap Chart
Since April 19, 2007, Perspective Therapeutics's market cap has increased from $65.60M to $113.89M, an increase of 73.61%. That is a compound annual growth rate of 2.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 113.90M | -44.28% |
| Dec 31, 2025 | 204.40M | -5.19% |
| Dec 31, 2024 | 215.60M | 91.13% |
| Dec 29, 2023 | 112.80M | 221.37% |
| Dec 30, 2022 | 35.10M | -36.18% |
| Dec 31, 2021 | 55.00M | 39.95% |
| Dec 31, 2020 | 39.30M | -6.65% |
| Dec 31, 2019 | 42.10M | 108.42% |
| Dec 31, 2018 | 20.20M | -8.18% |
| Dec 29, 2017 | 22.00M | -31.03% |
| Dec 30, 2016 | 31.90M | -38.18% |
| Dec 31, 2015 | 51.60M | -35.58% |
| Dec 31, 2014 | 80.10M | 317.19% |
| Dec 31, 2013 | 19.20M | -28.89% |
| Dec 31, 2012 | 27.00M | 41.36% |
| Dec 30, 2011 | 19.10M | -28.20% |
| Dec 31, 2010 | 26.60M | 30.39% |
| Dec 31, 2009 | 20.40M | 343.48% |
| Dec 31, 2008 | 4.60M | -90.09% |
| Dec 31, 2007 | 46.40M | -29.27% |
| Apr 19, 2007 | 65.60M | - |
View and export this data all the way back to 2007. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TriSalus Life Sciences | 139.13M |
| Pulmonx | 133.92M |
| Owlet | 132.67M |
| Apyx Medical | 121.53M |
| MaxCyte | 119.72M |
| Neuronetics | 111.15M |
| Nyxoah | 90.13M |
| Sera Prognostics | 79.14M |